We combine oncology expertise with advanced technology and analytics to organize real world data in order to guide decisions and actions.
Together, we can bring clarity to cancer care.
We curate EHR data that can be used to drive research and standardization in order to improve patient outcomes while also reducing costs at your institution.
We make clinical sense of claims data, providing insight into performance and related outcomes across sites in order to support value-based payment models.
Our deeply curated real world data accelerates drug development informing the decisions and actions that will deliver the best drugs to patients faster and at a lower cost.
Blood cancers make up more than 100 different diagnoses in the current classification system. And there are three main groups of blood cancer: leukemia, lymphoma, and myeloma.
One of the most common leukemias in adults is chronic lymphocytic leukemia (CLL). In this episode of Real World Talk, our host Ming He welcomes Paul Barr, MD, the medical director of the Clinical Trials Office of the Wilmot Cancer Institute. They talk about the importance of Blood Cancer Awareness Month, the development of CLL treatments, and the potential use of real-world data in blood cancer research.
Let’s work together to transform cancer care.
